138 related articles for article (PubMed ID: 15598581)
21. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
[TBL] [Abstract][Full Text] [Related]
22. Sinomenine promotes differentiation but impedes maturation and co-stimulatory molecule expression of human monocyte-derived dendritic cells.
Chen Y; Yang C; Jin N; Xie Z; Fei L; Jia Z; Wu Y
Int Immunopharmacol; 2007 Aug; 7(8):1102-10. PubMed ID: 17570327
[TBL] [Abstract][Full Text] [Related]
23. Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis.
Chan T; Chen Z; Hao S; Xu S; Yuan J; Saxena A; Qureshi M; Zheng C; Xiang J
Cancer Gene Ther; 2007 Apr; 14(4):409-20. PubMed ID: 17235354
[TBL] [Abstract][Full Text] [Related]
24. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
[TBL] [Abstract][Full Text] [Related]
25. Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells.
Bontkes HJ; Ruizendaal JJ; Kramer D; Santegoets SJ; Scheper RJ; de Gruijl TD; Meijer CJ; Hooijberg E
J Immunother; 2006; 29(2):188-200. PubMed ID: 16531819
[TBL] [Abstract][Full Text] [Related]
26. Functional alteration of myeloid dendritic cells through head and neck cancer.
Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B
Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
Bohnenkamp HR; Burchell JM; Taylor-Papadimitriou J; Noll T
J Immunol Methods; 2004 Nov; 294(1-2):67-80. PubMed ID: 15604017
[TBL] [Abstract][Full Text] [Related]
28. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
Li CD; Zhang WY; Yuan CL; Han LY
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
[TBL] [Abstract][Full Text] [Related]
29. Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation.
Boissel N; Rousselot P; Raffoux E; Cayuela JM; Soulier J; Mooney N; Charron D; Dombret H; Toubert A; Rea D
J Leukoc Biol; 2006 Apr; 79(4):747-56. PubMed ID: 16461746
[TBL] [Abstract][Full Text] [Related]
30. Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy.
Hayden H; Friedl J; Dettke M; Sachet M; Hassler M; Dubsky P; Bachleitner-Hofmann T; Gnant M; Stift A
J Immunother; 2009; 32(6):638-54. PubMed ID: 19483645
[TBL] [Abstract][Full Text] [Related]
31. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive effects of soluble factors secreted by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes.
Kacani L; Wurm M; Schennach H; Braun I; Andrle J; Sprinzl GM
Oral Oncol; 2003 Oct; 39(7):672-9. PubMed ID: 12907206
[TBL] [Abstract][Full Text] [Related]
33. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma.
Jeong HS; Lee H; Ko Y; Son YI
Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627
[TBL] [Abstract][Full Text] [Related]
34. Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation.
Vasir B; Borges V; Wu Z; Grosman D; Rosenblatt J; Irie M; Anderson K; Kufe D; Avigan D
Br J Haematol; 2005 Jun; 129(5):687-700. PubMed ID: 15916692
[TBL] [Abstract][Full Text] [Related]
35. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
Erdmann M; Dörrie J; Schaft N; Strasser E; Hendelmeier M; Kämpgen E; Schuler G; Schuler-Thurner B
J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
[TBL] [Abstract][Full Text] [Related]
36. In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients.
Tobiásová Z; Pospísilová D; Miller AM; Minárik I; Sochorová K; Spísek R; Rob L; Bartůnková J
Clin Immunol; 2007 Jan; 122(1):18-27. PubMed ID: 17059893
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of monocyte-derived dendritic cells under the influence of platelets.
Nguyen XD; Müller-Berghaus J; Kälsch T; Schadendorf D; Borggrefe M; Klüter H
Cytotherapy; 2008; 10(7):720-9. PubMed ID: 18985478
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
O-Sullivan I; Kim TS; Chopra A; Cohen EP
Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482
[TBL] [Abstract][Full Text] [Related]
39. Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates.
Inzkirweli N; Gückel B; Sohn C; Wallwiener D; Bastert G; Lindner M
Anticancer Res; 2007; 27(4B):2121-9. PubMed ID: 17695495
[TBL] [Abstract][Full Text] [Related]
40. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
